Table of Contents
The Emerging 5 Generics industry guide provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Features and benefits
* Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five generics market
* Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five generics market
* Leading company profiles reveal details of key generics market players’ emerging five operations and financial performance
* Add weight to presentations and pitches by understanding the future growth prospects of the emerging five generics market with five year forecasts
* Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
These countries contributed $84.0 billion to the global generics industry in 2015, with a compound annual growth rate (CAGR) of 17% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $168.0 billion in 2020, with a CAGR of 14.9% over the 2015-20 period.
Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of $56.6 billion in 2015. This was followed by India and Brazil with a value of $13.1 and $6.9 billion, respectively.
China is expected to lead the generics industry in the top five emerging nations, with a value of $114.8 billion in 2020, followed by India and Mexico with expected values of $32.3 and $11.1 billion, respectively.
Your key questions answered
* What was the size of the emerging five generics market by value in 2015?
* What will be the size of the emerging five generics market in 2020?
* What factors are affecting the strength of competition in the emerging five generics market?
* How has the market performed over the last five years?
* How large is the emerging five generics market in relation to its regional counterparts?
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...
PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...